Literature DB >> 12531234

The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice.

Ningshan Wang1, Avi Orr-Urtreger, Amos D Korczyn.   

Abstract

Neuronal nicotinic acetylcholine receptors (nAChR), composed of 12 subunits (alpha2-alpha10, beta2-beta4), are expressed in autonomic ganglia, playing a central role in autonomic transmission. The repertoire of nicotinic subunits in autonomic ganglia includes alpha3, alpha5, alpha7, beta2 and beta4 subunits. In the last 10 years, heterologous expression studies have revealed much about the nature of neuronal nAChRs. However, there is only limited understanding of subunit actions in autonomic system. Functional deletions of subunit by gene knockout in animals could overcome these limitations. We review recent studies on nAChRs on autonomic ganglia for physiological and pharmacological properties and potential locations of the subunits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12531234     DOI: 10.1016/s0301-0082(02)00106-5

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  21 in total

1.  Shared long-range regulatory elements coordinate expression of a gene cluster encoding nicotinic receptor heteromeric subtypes.

Authors:  Xiaohong Xu; Michael M Scott; Evan S Deneris
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

2.  Selective deletion of the alpha5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse.

Authors:  Harald Fischer; Avi Orr-Urtreger; Lorna W Role; Sigismund Huck
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

3.  The Effects of Nerve Growth Factor on Nicotinic Synaptic Transmission in Mouse Airway Parasympathetic Neurons.

Authors:  Letitia A Weigand; Kevin Kwong; Allen C Myers
Journal:  Am J Respir Cell Mol Biol       Date:  2015-10       Impact factor: 6.914

Review 4.  The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer.

Authors:  Ma Reina D Improgo; Michael D Scofield; Andrew R Tapper; Paul D Gardner
Journal:  Prog Neurobiol       Date:  2010-06-04       Impact factor: 11.685

5.  Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study.

Authors:  George Apostol; Walid Abi-Saab; Christopher J Kratochvil; Lenard A Adler; Weining Z Robieson; Laura M Gault; Yili L Pritchett; David Feifel; Michelle A Collins; Mario D Saltarelli
Journal:  Psychopharmacology (Berl)       Date:  2011-07-12       Impact factor: 4.530

6.  Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes.

Authors:  Reinhard David; Anna Ciuraszkiewicz; Xenia Simeone; Avi Orr-Urtreger; Roger L Papke; J M McIntosh; Sigismund Huck; Petra Scholze
Journal:  Eur J Neurosci       Date:  2010-03-03       Impact factor: 3.386

7.  Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials.

Authors:  Timothy E Wilens; Laura M Gault; Ann Childress; Christopher J Kratochvil; Lindsey Bensman; Coleen M Hall; Evelyn Olson; Weining Z Robieson; Tushar S Garimella; Walid M Abi-Saab; George Apostol; Mario D Saltarelli
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-11-25       Impact factor: 8.829

8.  Temporally- and spatially-regulated transcriptional activity of the nicotinic acetylcholine receptor beta4 subunit gene promoter.

Authors:  L Bruschweiler-Li; Y F Fuentes Medel; M D Scofield; E B T Trang; S A Binke; P D Gardner
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

9.  Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain.

Authors:  Michael J Marks; Charles R Wageman; Sharon R Grady; Murali Gopalakrishnan; Clark A Briggs
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

Review 10.  Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition.

Authors:  Timothy E Wilens; Michael W Decker
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.